Structure Assignment, Total Synthesis, and Antiviral Evaluation of Cycloviracin B1

Journal of the American Chemical Society

Volumn 125, Issue 43, 2003, Pages 13132-13142

  Fürstner, Alois ^a   Albert, Martin ^a   Mlynarski, Jacek ^a   Matheu, Maribel ^a   DeClercq, Erik ^b  

^a MAX PLANCK INSTITUT FÜR KOHLENFORSCHUNG   (Germany)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; DRUG PRODUCTS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STEREOCHEMISTRY; SYNTHESIS (CHEMICAL);

ACTIVATING AGENTS;

LIPIDS;

2 CHLORO 1,3 DIMETHYLIMIDAZOLINIUM CHLORIDE; AGLYCONE DERIVATIVE; BETA GLYCOSIDE DERIVATIVE; CYCLOVIRACIN B1; CYCLOVIRACIN DERIVATIVE; FATTIVIRACIN DERIVATIVE; FATTY ACID; GLUCOSE DERIVATIVE; GLYCOCONJUGATE; GLYCOLIPID; GLYCOSIDE; HYDROXY FATTY ACID; IMIDAZOLE DERIVATIVE; LIGAND; POLYGLACTIN; REAGENT; SULFONE DERIVATIVE; TETRAZOLYL SULFONE; UNCLASSIFIED DRUG; ZINC;

ADDITION REACTION; ANTIVIRAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL BINDING; CHIRALITY; DRUG ACTIVITY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; FUNCTIONAL ASSESSMENT; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; JULIA KOCIENSKI OLEFINATION; MACRODILACTONIZATION; NONHUMAN; REACTION ANALYSIS; STEREOCHEMISTRY;

ANTIVIRAL AGENTS; CELL LINE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; VACCINIA VIRUS; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 0142214614     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja036521e     Document Type: Article

References (118)

1. (a) Tsunakawa, M.; Komiyama, N.; Tenmyo, O.; Tomita, K.; Kawano, K.; Kotake, C.; Konishi, M.; Oki, T. J. Antibiot. 1992, 45, 1467.
2. (b) Tsunakawa, M.; Kotake, C.; Yamasaki, T.; Moriyama, T.; Konishi, M.; Oki, T. J. Antibiot. 1992, 45, 1472.
3. (c) Tsunakawa, M.; Yamasaki, T.; Tomita, K.; Osamu, T. EP 0 472 005 A1 (1991-07-26).
4. (a) Uyeda, M.; Yokomizu, K.; Miyamoto, Y.; Habib, E.-S. E. J. Antibiot. 1998, 51, 823.
5. (b) Yokomizo, K.; Miyamoto, Y.; Nagao, K.; Kumagae, E.; Habib, E.-S. E.; Suzuki, K.; Harada, S.; Uyeda, M. J. Antibiot. 1998, 51, 1035.
6. (c) Habib, E.-S. E.; Yokomizo, K.; Murata, K.; Uyeda, M. J. Antibiot. 2000, 53, 1420.
7. (d) Habib, E.-S. E.; Yokomizo, K.; Suzuki, K.; Uyeda, M. Biosci., Biotechnol., Biochem. 2001, 65, 861.
8. For information on the producing strain, see: Tomita, K.; Hoshino, Y.; Miyaki, T. Int. J. Syst. Bacteriol. 1993, 43, 297.
9. (a) Schaeffer, H. J.; Beauchamp, L.; de Miranda, P.; Elion, G. B.; Bauer, D. J.; Collins, P. Nature 1978, 272, 583.
10. (b) Elion G. B.; Furman, P. A.; Fyfe, J. A.; de Miranda, P.; Beauchamp, L.; Schaeffer, H. J. Proc. Natl. Acad. Sci. U S. A. 1977, 74, 5716.
11. (c) Whitley, R. J.; Gnann, J. W. N. Engl. J. Med. 1992, 327, 782.
12. Habib, E.-S. E.; Yokomizo, K.; Nagao, K.; Harada, S.; Uyeda, M. Biosci., Biotechnol., Biochem. 2001, 65, 683.
13. This applies to all 13 individual fattiviracins known to date, cf. refs 2 and 5.
14. (a) Fürstner, A.; Jeanjean, F.; Razon, P. Angew. Chem., Int. Ed. 2002, 41, 2097.
15. (b) Fürstner, A., Jeanjean, F.; Razon, P.; Wirtz, C.; Mynott, R. Chem. Eur. J. 2003, 9, 307.
16. (c) Fürstner, A.; Jeanjean, F.; Razon, P.; Wirtz, C.; Mynott, R. Chem. Eur. J. 2003, 9, 320.
17. (a) Fürstner, A.; Müller, T. J. Am. Chem. Soc. 1999, 121, 7814.
18. (b) Fürstner, A.; Müller, T. J. Org. Chem. 1998, 63, 424.
19. (c) Fürstner, A.; Radkowski, K.; Grabowski, J.; Wirtz, C.; Mynott, R. J. Org. Chem. 2000, 65, 8758.
20. (d) Lehmann, C. W.; Fürstner, A.; Müller, T. Z. Kristallogr. 2000, 215, 114.
21. (a) Fürstner, A.; Konetzki, I. J. Org. Chem. 1998, 63, 3072.
22. (b) Fürstner, A.; Konetzki, I. Tetrahedron 1996, 52, 15071.
23. For preliminary communications, see: (a) Fürstner, A.; Albert, M.; Mlynarski, J.; Matheu, M. J. Am. Chem. Soc. 2002, 124, 1168.
24. (b) Fürstner, A.; Mlynarski, J.; Albert, M. J. Am. Chem. Soc. 2002, 124, 10274.
25. (a) Poss, C. S.; Schreiber, S. L. Acc. Chem. Res. 1994, 27, 9.
26. (b) Magnuson, S. R. Tetrahedron 1995, 51, 2167.
27. Fürstner, A. In Templated Organic Synthesis; Diederich, F., Stang, P. J., Eds.; Wiley-VCH: Weinheim, 2000; pp 249-273.
28. (a) For recent studies on the synthesis of macrodiolides by nontemplated cyclodimerization reactions, see the following leading references and a comprehensive compilation of pertinent literature: Su, Q.; Beeler, A. B.; Lobkovsky, E.; Porco, J. A., Jr.; Panek, J. S. Org. Lett. 2003, 5, 2149.
29. (b) For the synthesis of a natural product from our laboratory by an RCM-based cyclodimerization process, see: Fürstner, A.; Thiel, O. R.; Ackermann, L. Org. Lett. 2001, 3, 449.
30. For a study on cyclic oligosaccharides acting as crown ethers, see: Shizuma, M.; Kadoya, Y.; Takai, Y.; Imamura, H.; Yamada, H.; Takeda, T.; Arakawa, R.; Takahashi, S.; Sawada, M. J. Org. Chem. 2002, 67, 4795 and literature cited therein.
31. Velarde, S.; Urbina, J.; Pena, M. R. J. Org. Chem. 1996, 61, 9541.
32. For a shortcut synthesis, see: (a) Fürstner, A.; Langemann, K. J. Org. Chem. 1996, 61, 3942.
33. (b) Fürstner, A.; Langemann, K. Synthesis 1997, 792.
34. (c) Fürstner, A.; Ackermann, L.; Beck, K.; Hori, H.; Koch, D.; Langemann, K.; Liebl, M.; Six, C.; Leitner, W. J. Am. Chem. Soc. 2001, 123, 9000.
35. Only very few examples of ring-opening Claisen condensations are known using four- to six-membered lactones as the substrates, cf: (a) Bone, E. A.; Davidson, A. H.; Lewis, C. N.; Todd, R. S. J. Med. Chem. 1992, 35, 3388.
36. (b) Yamaguchi, M.; Nakamura, S.; Okuma, T.; Minami, T. Tetrahedron Lett. 1990, 31, 3913.
37. (c) Shimizu, M.; Ishii, K.; Fujisawa, T. Chem. Lett. 1997, 8, 765.
38. For comprehensive treatises, see: (a) Noyori, R. Asymmetric Catalysis in Organic Synthesis; Wiley: New York, 1994.
39. (b) Ohkuma, T.; Noyori, R. In Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer: Berlin, 1999; Vol. 1; pp 199-246.
40. The order of silylation and hydrogenation can also be inversed. In this case, however, the overall yield of product 6 is somewhat lower due to partial cleavage of the terminal TBDPS group during the asymmetric reduction step.
41. Wang, Y.; Mao, J.; Cai, M. Synth. Commun. 1999, 29, 2093.
42. (a) Bourke, D. G.; Collins, D. J.; Hibberd, A. I.; McLeod, M. D. Aust. J. Chem. 1996, 49, 425.
43. (b) Hoch, M.; Heinz, E.; Schmidt, R. R. Carbohydr. Res. 1989, 191, 21.
44. General discussions: (a) Paulsen, H. Angew. Chem., Int. Ed. Engl. 1982, 21, 155.
45. (b) Schmidt, R. R. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon: Oxford, 1991; Vol. 6; pp 33-61.
46. (c) Toshima, K.; Tatsuta, K. Chem. Rev. 1993, 93, 1503.
47. Pertinent reviews on the trichloroacetimidate method: (a) Schmidt, R. R. Angew. Chem., Int. Ed. Engl. 1986, 25, 212.
48. (b) Schmidt, R. R.; Kinzy, W. Adv. Carbohydr. Chem. Biochem. 1994, 50, 21.
49. Schmidt, R. R.; Behrendt, M.; Toepfer, A. Synlett 1990, 694.
50. (a) Isobe, T.; Ishikawa, T. J. Org. Chem. 1999, 64, 5832.
51. (b) Isobe, T.; Ishikawa, T. J. Org. Chem. 1999, 64, 6984.
52. (c) Isobe, T.; Ishikawa, T. J. Org. Chem. 1999, 64, 6989.
53. (d) See also: Fujisawa, T.; Mori, T.; Fukumoto, K.; Sato, T. Chem. Lett. 1982, 1891.
54. For a related cyclotrimerization en route to the glycolipid anthrobacilin A, see: Garcia, D. M.; Yamada, H.; Hatakeyama, S.; Nishizawa, M. Tetrahedron Lett. 1994, 35, 3325.
55. For an application of these reagents in organometallic chemistry, see: Fürstner, A.; Seidel, G.; Kremzow, D.; Lehmann, C. W. Organometallics 2003, 22, 907.
56. Although the closely related shift values of the glucokinase activating macrodiolide glucolipsin A seem to suggest that this particular compound which contains ah extra methyl branch at the adjacent position - might also be (3R,3′R) configured, a recent total synthesis by our group shows that glucolipsin incorporates in fact a (2R,3S)-configured syn aldol entity. For the isolation of glucolipsin, see: Qian-Cutrone, J.; Ueki, T.; Huang, S.; Mookhtiar, K. A.; Ezekiel, R.; Kalinowski, S. S.; Brown, K. S.; Golik, J.; Lowe, S.; Pirnik, D. M.; Hugill, R.; Veitch, J. A.; Klohr, S. E.; Whitney, J. L.; Manly, S. P. J. Antibiot. 1999, 52, 245. (diagram presented)
57. For a discussion, see: Fürstner, A. Synlett 1999, 1523.
58. The synthesis of this compound is outlined in the Supporting Information.
59. Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Bull. Chem. Soc. Jpn. 1979, 52, 1989.
60. (a) Hyoda, T.; Tsuchira, Y.; Sekine, A.; Amano, T. Jpn. Kokai Tokkyo Koho Jpn. Pat. 11246587 (1999-09-14).
61. (b) See also: Takahashi, S.; Hosoya, M.; Koshino, H.; Nakata, T. Org. Lett. 2003, 5, 1555.
62. For methods allowing the determination of the configuration of secondary alcohols by using sugar derivatives as derivatizing agents, see the following for leading references and literature cited therein: (a) Trujillo, M.; Morales, E. Q.; Vazquez, J. T. J. Org. Chem. 1994, 59, 6637.
63. (b) Kobayashi, M. Tetrahedron 2002, 58, 9365.
64. Bellucci, G.; Chiappe, C.; D'Andrea, F. Tetrahedron: Asymmetry 1995, 6, 221.
65. (a) Halcomb, R. L.; Danishefsky, S. J. J. Am. Chem. Soc. 1989, 111, 6661.
66. (b) Review: Danishefsky, S. J.; Bilodeau, M. T. Angew. Chem., Int. Ed. Engl. 1996, 35, 1380.
67. Enantiopure propene oxide is commercially available or can be conveniently prepared on a large scale in optically active form using Jacobsens's excellent HKR method, cf.: (a) Tokunaga, M.; Larrow, J. F.; Kakiuchi, F.; Jacobsen, E. N. Science 1997, 277, 936.
68. (b) Furrow, M. E.; Schaus, S. E.; Jacobsen, E. N. J. Org. Chem. 1998, 63, 6776.
69. (c) Keith, J. M.; Larrow, J. F.; Jacobsen, E. N. Adv. Synth. Catal. 2001, 343, 5.
70. Rozema, M. J.; Eisenberg, C.; Lütjens, H.; Ostwald, R.; Belyk, K.; Knochel, P. Tetrahedron Lett. 1993, 34, 3115.
71. (a) Takahashi, H.; Kawakita, T.; Ohno, M.; Yoshioka, M.; Kobayashi, S. Tetrahedron 1992, 48, 5691.
72. (b) Takahashi, H.; Yoshioka, M.; Shibasaki, M.; Ohno, M.; Imai, N.; Kobayashi, S. Tetrahedron 1995, 51, 12013.
73. (c) Knochel, P. Synlett 1995, 393.
74. 1H NMR spectra which are also distinctly different for the pairs of stereoisomers 31/33, 42/43, 44/45. Particularly diagnostic is the shift of the terminal methyl group of the fatty acid chain which resonates at Δ = 1.34 ppm in the 17S-configured compounds but at Δ = 1.31 ppm in the 17R-configured products. The pertinent shift in the natural product is Δ = 1.34 ppm.
75. If the fatty acids are drawn in a zigzag conformation, all hydroxyl groups are located on the same side; the fact that the centers at C-17' and C-19 are S-configured while the other ones are R-configured simply reflects the formalism of the Cahn - Ingold-Prelog nomenclature.
76. (a) Liu, H.-J.; Wang, D.-X.; Kim, J. B.; Browne, E. N. C.; Wang, Y. Can, J. Chem. 1997, 75, 899,
77. (b) Dave, V.; Warnhoff, E. W. J. Org. Chem. 1983, 48, 2590.
78. Fouque, E.; Rousseau, G. Synthesis 1989, 661.
79. Note again the formalism of the Chan-Ingold-Prelog nomenclature. The use of the (2R)-configured aldehyde 58 will ultimately result in a (19S)-configured cycloviracin derivative due to change in priorities of the substituents at that center.
80. (a) Brooks, D. W.; Lu, L. D. L.; Masamune, S. Angew. Chem., Int. Ed. Engl. 1979, 18, 72.
81. (b) For an advanced application, see the total synthesis of thienamycin reported by the Merck Laboratories: Salzmann, T. N.; Ratcliffe, R. W.; Christensen, B. G.; Bouffard, F. A. J. Am. Chem. Soc. 1980, 102, 6161.
82. For a convenient preparation of the magnesium carboxylate, see: Page, P. C. B.; Moore, J. P. G.; Mansfield, I.; McKenzie, M. J.; Bowler, W. B.; Gallagher, J. A. Tetrahedron 2001, 57, 1837.
83. Fürstner, A.; Konetzki, I. Tetrahedron Lett. 1998, 39, 5721.
84. (a) Kochetkov, N. K.; Khorlin, A. J.; Bochkov, A. F. Tetrahedron Lett. 1964, 5, 289.
85. (b) Kochetkov, N. K.; Khorlin, A. J.; Bochkov, A. F. Tetrahedron 1967, 23, 693.
86. (c) For the use of TMSOTf as promotor in Kochetkov-type ortho ester rearrangements, see: Ogawa, T.; Beppu, K.; Nakabayashi, S. Carbohydr. Res. 1981, 93, C6.
87. (a) Sharpless, K. B.; Young, M. W. J. Org. Chem. 1975, 40, 947.
88. (b) Grieco, P. A.; Gilman, S.; Nishizawa, M. J. Org. Chem. 1976, 41, 1485.
89. (a) Julia, M.; Paris, J.-M. Tetrahedron Lett. 1973, 14, 4833.
90. (b) Kocienski, P. J.; Lythgoe, B.; Ruston, S. J. Chem. Soc., Perkin Trans. 1 1978, 829.
91. (c) Baudin, J. B.; Hareau, G.; Julia, S. A.; Ruel, O. Tetrahedron Lett. 1991, 32, 1175.
92. (a) Blakemore, P. R.; Cole, W. J.; Kocienski, P. J.; Morley, A. Synlett 1998, 26.
93. (b) For a recent review, see: Blakemore, P. R. J. Chem. Soc., Perkin Trans. 1 2002, 2563.
94. See the following for leading references on the applications of Julia-Kocienski olefination reactions to the total synthesis of complex targets: (a) Kang, S. H.; Jeong, J. W.; Hwang, Y. S.; Lee, S. B. Angew. Chem., Int. Ed. 2002, 41, 1392.
95. (b) Lee, E.; Song, H. Y.; Kang, J. W.; Kim, D.-S.; Jung, C.-K.; Joo, J. M. J. Am. Chem. Soc. 2002, 124, 384.
96. (c) Lee, E.; Choi, S. J.; Kim, H.; Han, H. O.; Kim, Y. K.; Min, S. J.; Son, S. H.; Lim, S. M.; Jang, W. S. Angew. Chem., Int. Ed. 2002, 41, 176.
97. (d) Liu, P.; Jacobsen, E. N. J. Am. Chem. Soc. 2001, 123, 10772.
98. (e) Smith, A. B.; Safonov, I. G.; Corbett, R. M. J. Am. Chem. Soc. 2001, 123, 12420.
99. (f) Smith, A. B.; Brandt, B. M. Org. Lett. 2001, 3, 1685.
100. (g) Mulzer, J.; Öhler, E. Angew. Chem. Int. Ed. 2001, 40, 3842.
101. (h) Takano, D.; Nagamitsu, T.; Ui, H.; Shiomi, K.; Yamaguchi, Y.; Masuma, R.; Kuwajima, I.; Omura, S. Org. Lett. 2001, 3, 2289.
102. (i) Williams, D. R.; Cortez, G. S.; Bogen, S. L.; Rojas, C. M. Angew. Chem., Int. Ed. 2000, 39, 4612.
103. (j) Harris, J. M.; O'Doherty, G. A. Org. Lett. 2000, 2, 2983.
104. (k) Williams D. R.; Clark, M. P.; Emde, U.; Berliner, M. A. Org. Lett. 2000, 2, 3023.
105. (l) Metternich, R.; Denni, D.; Thai, B.; Sedrani, R. J. Org. Chem. 1999, 64, 9632.
106. (m) Lear, M. J.; Hirama, M. Tetrahedron Lett. 1999, 40, 4897.
107. (n) Williams, D. R.; Brooks, D. A.; Berliner, M. A. J. Am. Chem. Soc. 1999, 121, 4924.
108. (o) Smith, A. B.; Wan, Z. J. Org. Chem. 2000, 65, 3738.
109. (p) Lautens, M.; Colucci, J. T.; Hiebert, S.; Smith, N. D.; Bouchain, G. Org. Lett. 2002, 4, 1879.
110. (q) Hayes, P. Y.; Kitching, W. J. Am. Chem. Soc. 2002, 124, 9718.
111. (r) Ahmed, A.; Hoegenauer, E. K.; Enev, V. S.; Hanbauer, M.; Kaehlig, H. ; Öhler, E.; Mulzer, J. J. Org. Chem. 2003, 68, 3026.
112. (a) Hata, T.; Sekine, M. Chem. Lett. 1974, 837.
113. (b) Nakagawa, I.; Aki, K.; Hata, T. J. Chem. Soc., Perkin Trans. 1 1983, 1315.
114. (c) Fürstner, A. Liebigs Ann. Chem. 1993, 1211.
115. Schultz, H. S.; Feyermuth, H. B.; Buc, S. R. J. Org. Chem. 1963, 28, 1140.
116. See the following for general reviews on diorganozinc addition reactions to aldehydes: (a) refs 18a and 38c.
117. (b) Soai, K.; Niwa, S. Chem. Rev. 1992, 92, 833.
118. (c) Soai, K.; Shibata, T. In Comprehensive Asymmetric Catalysis, Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer, Berlin, 1999; Vol. 2; pp 911-922.